Metropolitan Life Insurance Company (MetLife)’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,579
| Closed | -$193K | – | 2368 |
|
|
2021
Q4 | $193K | Buy |
2,579
+7
| +0.3% | +$526 | ﹤0.01% | 2048 |
|
|
2021
Q3 | $195K | Sell |
2,572
-103
| -4% | -$7.97K | ﹤0.01% | 2088 |
|
|
2021
Q2 | $207K | Buy |
2,675
+58
| +2% | +$4.48K | ﹤0.01% | 2113 |
|
|
2021
Q1 | $184K | Buy |
2,617
+65
| +3% | +$4.91K | ﹤0.01% | 2078 |
|
|
2020
Q4 | $181K | Sell |
2,552
-111
| -4% | -$6.97K | ﹤0.01% | 1999 |
|
|
2020
Q3 | $153K | Sell |
2,663
-38
| -1% | -$2.27K | ﹤0.01% | 1948 |
|
|
2020
Q2 | $164K | Sell |
2,701
-527
| -16% | -$32.6K | ﹤0.01% | 1935 |
|
|
2020
Q1 | $177K | Sell |
3,228
-58
| -2% | -$3.89K | ﹤0.01% | 1663 |
|
|
2019
Q4 | $237K | Buy |
3,286
+11
| +0.3% | +$749 | ﹤0.01% | 1794 |
|
|
2019
Q3 | $217K | Sell |
3,275
-72
| -2% | -$4.63K | ﹤0.01% | 1823 |
|
|
2019
Q2 | $208K | Hold |
3,347
| – | – | ﹤0.01% | 1871 |
|
|
2019
Q1 | $181K | Sell |
3,347
-168
| -5% | -$9.44K | ﹤0.01% | 1958 |
|
|
2018
Q4 | $206K | Buy |
3,515
+26
| +0.7% | +$1.63K | ﹤0.01% | 1803 |
|
|
2018
Q3 | $230K | Sell |
3,489
-355
| -9% | -$23.5K | ﹤0.01% | 1906 |
|
|
2018
Q2 | $254K | Sell |
3,844
-259
| -6% | -$17.4K | ﹤0.01% | 1784 |
|
|
2018
Q1 | $274K | Sell |
4,103
-48
| -1% | -$3.23K | ﹤0.01% | 1682 |
|
|
2017
Q4 | $272K | Sell |
4,151
-209
| -5% | -$13.6K | ﹤0.01% | 1702 |
|
|
2017
Q3 | $280K | Buy |
4,360
+399
| +10% | +$25.8K | ﹤0.01% | 2069 |
|
|
2017
Q2 | $255K | Sell |
3,961
-281
| -7% | -$17.7K | ﹤0.01% | 2181 |
|
|
2017
Q1 | $259K | Hold |
4,242
| – | – | ﹤0.01% | 2099 |
|
|
2016
Q4 | $247K | Sell |
4,242
-98
| -2% | -$5.78K | ﹤0.01% | 2215 |
|
|
2016
Q3 | $251K | Sell |
4,340
-43
| -1% | -$2.53K | ﹤0.01% | 2195 |
|
|
2016
Q2 | $253K | Sell |
4,383
-125
| -3% | -$7.17K | ﹤0.01% | 2166 |
|
|
2016
Q1 | $272K | Hold |
4,508
| – | – | ﹤0.01% | 1964 |
|
|
2015
Q4 | $246K | Hold |
4,508
| – | – | ﹤0.01% | 2098 |
|
|
2015
Q3 | $256K | Hold |
4,508
| – | – | ﹤0.01% | 2107 |
|
|
2015
Q2 | $246K | Sell |
4,508
-342
| -7% | -$18.8K | ﹤0.01% | 2263 |
|
|
2015
Q1 | $264K | Hold |
4,850
| – | – | ﹤0.01% | 1908 |
|
|
2014
Q4 | $226K | Hold |
4,850
| – | – | ﹤0.01% | 2327 |
|
|
2014
Q3 | $223K | Buy |
4,850
+124
| +3% | +$5.8K | ﹤0.01% | 2295 |
|
|
2014
Q2 | $219K | Buy |
4,726
+80
| +2% | +$3.77K | ﹤0.01% | 2454 |
|
|
2014
Q1 | $216K | Hold |
4,646
| – | – | ﹤0.01% | 2413 |
|
|
2013
Q4 | $192K | Hold |
4,646
| – | – | ﹤0.01% | 2499 |
|
|
2013
Q3 | $170K | Buy |
4,646
+163
| +4% | +$6.16K | ﹤0.01% | 2532 |
|
|
2013
Q2 | $166K | Buy |
+4,483
| New | +$160K | ﹤0.01% | 2465 |
|
Other funds holding DOX
BGC
CI
Metropolitan Life Insurance Company (MetLife)'s DOX Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Amdocs (DOX) in Q1 2022, closing a stake of 2,579 shares — an estimated $193K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in DOX in Q2 2013 and held it in 35 quarters. The position peaked at $280K in Q3 2017. 434 funds tracked by Wall St. Rank hold DOX as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Amdocs position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,579 Amdocs shares in Q1 2022, an estimated $193K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Amdocs in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Amdocs position peaked at $280K in Q3 2017.
- 434 funds tracked by Wall St. Rank held Amdocs as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.